 |
 |

Histamine2 Antagonists in Allergic RhinitisPossible Role in the Control of Cellular Immune Reaction
Benedetto Testa, MD;
Carlo Mesolella, MD;
Federico Costa, MD;
Pier Giorgio Catalanotti, MD;
Nunzia Benedetto, MD;
Silvana Mattera, PhD
Arch Otolaryngol Head Neck Surg. 1986;112(4):432-433.
Abstract
We studied effects of monoclonal antibodies on lymphocyte subpopulations in patients with allergic rhinitis treated with histamine2 antagonists. The OKT4/OKT8 ratio after treatment showed a statistically significant decrease compared with initial values, the expression of a relative increase in the OKT8 subpopulation containing the suppressor fraction. In control patients no significant variations were observed. These results confirm our hypothesis that histamine2 antagonists act in allergic rhinitis by modulating the activity of T-suppressor lymphocytes reduced in atopic patients.
(Arch Otolaryngol Head Neck Surg 1986;112:432-433)
Author Affiliations
From the Institutes of Otolaryngology (Drs Testa, Mesolella, and Costa) and Microbiology (Drs Catalanotti, Benedetto, and Mattera), First School of Medicine, University of Naples (Italy).
Footnotes
Accepted for publication April 16, 1985.
Reprint requests to Clinica Otorinolaringoiatrica, I Facoltà di Medicina dell'Università di Napoli, Ospedale Gesù e Maria, via Cotugno 3, 80135 Naples, Italy (Dr Testa).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Histamine 2 Antagonists in Allergic Rhinitis: Relationship of Clinical Response and Serum Concentrations of Total and Specific IgE Antibody Levels
Testa et al.
Arch Otolaryngol Head Neck Surg 1989;115:950-953.
ABSTRACT
Allergy and Antihistamines: A New Riddle
Theoharides
Arch Dermatol 1986;122:995-996.
ABSTRACT
|